Levodopa

mechanistic target of rapamycin kinase ; Homo sapiens







7 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32426479 RasGRP1 is a causal factor in the development of l-DOPA-induced dyskinesia in Parkinson's disease. 2020 May 3
2 29992529 MTOR Pathway-Based Discovery of Genetic Susceptibility to L-DOPA-Induced Dyskinesia in Parkinson's Disease Patients. 2019 Mar 2
3 32146463 Regulation of Protein Synthesis and Apoptosis in Lymphocytes of Parkinson Patients: The Effect of Dopaminergic Treatment. 2019 1
4 24144882 New genetic insights highlight 'old' ideas on motor dysfunction in dystonia. 2013 Dec 1
5 22179112 Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia. 2011 Dec 18 2
6 19622830 Thwarting dyskinesia by targeting mTORC1. 2009 Jul 21 1
7 19622833 Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia. 2009 Jul 21 2